Topical anti-inflammatory potential of quercetin in lipid-based nanosystems: In vivo and in vitro evaluation

Pharmaceutical Research

Volumn 31, Issue 4, 2014, Pages 959-968

  Caddeo, Carla ^a   Díez Sales, Octavio ^b,c   Pons, Ramon ^d   Fernàndez Busquets, Xavier ^e,f,g   Fadda, Anna Maria ^a   Manconi, Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^d INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^e INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^f CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

Author keywords

dermal fibroblasts; mice; quercetin; skin inflammation; vesicles

Indexed keywords

LIPOSOME; MACROGOL 400; MYELOPEROXIDASE; QUERCETIN; ANTIINFLAMMATORY AGENT; DRUG CARRIER; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MOUSE; NONHUMAN; PHOSPHOLIPID VESICLE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN EDEMA; SKIN FIBROBLAST; SKIN IRRITATION; SKIN PENETRATION; 3T3 CELL LINE; ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; INTRADERMAL DRUG ADMINISTRATION; PHYSIOLOGY; PROCEDURES; SKIN ABSORPTION; X RAY DIFFRACTION;

3T3 CELLS; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; FEMALE; LIPOSOMES; MICE; NANOPARTICLES; QUERCETIN; SKIN ABSORPTION; X-RAY DIFFRACTION;

EID: 84897029547     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1215-0     Document Type: Article

References (24)

1. Caddeo C, Teskač K, Sinico C, Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm. 2008;363:183-91.
2. Caddeo C, Manconi M, Fadda AM, Lai F, Lampis S, Diez-Sales O, et al. Nanocarriers for antioxidant resveratrol: formulation approach, vesicle self-assembly and stability evaluation. Colloid Surf B-Biointerfaces. 2013;111:327-32.
3. Pando D, Caddeo C, Manconi M, Fadda AM, Pazos C. Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol. J Pharm Pharmacol. 2013;65:1158-67.
4. Chessa M, Caddeo C, Valenti D, Manconi M, Sinico C, Fadda AM. Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin. Pharmaceutics. 2011;3:497-509.
5. Date AA, Nagarsenker MS, Patere S, Dhawan V, Gude RP, Hassan PA, et al. Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration. Mol Pharm. 2011;8:716-26.
6. Vicentini FTMC, Fonseca YM, Pitol DL, Iyomasa MM, Bentley MVLB, Fonseca MJV. Evaluation of protective effect of a water-in-oil microemulsion incorporating quercetin against UVB-induced damage in hairless mice skin. J Pharm Pharm Sci. 2010;13:274-85.
7. Wagner C, Vargas AP, Roos DH, Morel AF, Farina M, Nogueira CW, et al. Comparative study of quercetin and its two glycoside derivatives quercetin and rutin against methylmercury (MgHg)-induced ROS production in rat brain slices. Arch Toxicol. 2010;84:89-97.
8. Chen-yu G, Chun-fen Y, Qi-lu L, Qi T, Yan-wei X, Wei-na L, et al. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm. 2012;430:292-8.
9. Bose S, Du Y, Takhistov P, Michniak-Kohn B. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. Int J Pharm. 2013;441:56-66.
10. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 1990;186:343-55.
11. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radical Biol Med. 1995;19:481-6.
12. Tan Q, Liu W, Guo C, Zhai G. Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Int J Nanomed. 2011;6:1621-30.
13. Montenegro L, Carbone C, Maniscalco C, Lambusta D, Nicolosi G, Ventura CA, et al. In vitro evaluation of quercetin-3-O-acyl esters as topical prodrugs. Int J Pharm. 2007;336:257-62.
14. Censi R, Martena V, Hoti E, Malaj L, Di MP. Permeation and skin retention of quercetin from microemulsions containing Transcutol® P. Drug Dev Ind Pharm. 2012;38:1128-33.
15. Cadena PG, Pereira MA, Cordeiro RBS, Cavalcanti IMF, Barros Neto B, Pimentel Mdo C, et al. Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta. 2013;1828:309-16.
16. Stewart JC. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem. 1980;104:10-4.
17. Pabst G, Rappolt M, Amenitsch H, Laggner P. Structural information from multilamellar liposomes at full hydration: full q-range fitting with high quality x-ray data. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 2000;62:4000-9.
18. De Vry CG, Valdez M, Lazarov M, Muhr E, Buelow R, Fong T, et al. Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model. J Invest Dermatol. 2005;125:473-81.
19. Caddeo C, Diez Sales O, Valenti D, Ruiz Saurí A, Fadda AM, Manconi M. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs. Int J Pharm. 2013;443:128-36.
20. De Young LM, Kheifets JB, Ballaron SJ, Young JM. Edema and cell infiltration in the phorbol ester-treated mouse ear aretemporally separate and can be differentially modulated by pharmacologic agents. Agents Actions. 1989;26:335-41.
21. Sato H, Nakayama Y, Yamashita C, Uno H. Anti-inflammatory effects of tacalcitol (1,24(R)(OH)2D3, TV-02) in the skin of TPA-treated hairless mice. J Dermatol. 2004;31:200-17.
22. Manconi M, Sinico C, Caddeo C, Vila AO, Valenti D, Fadda AM. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm. 2011;412:37-46.
23. Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Lampis S, et al. Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability. Eur J Pharm Biopharm. 2012;82:352-9.
24. Caddeo C, Manconi M, Valenti D, Maccioni AM, Fadda AM, Sinico C. The role of Labrasol® in the enhancement of the cutaneous bioavailability of minoxidil in phospholipid vesicles. Res J Pharm Technol. 2012;5:1563-9.